Health care stocks were steady premarket Wednesday as the Health Care Select Sector SPDR Fund (XLV) was inactive and the iShares Biotechnology ETF (IBB) was nearly 0.1% lower recently.
Patterson (PDCO) shares fell by over 8% after it reported declines in fiscal Q1 non-GAAP earnings and net sales.
SpringWorks Therapeutics (SWTX) shares were 1.1% higher after saying the US Food and Drug Administration had accepted a New Drug Application for its experimental therapy, mirdametinib, to treat adult and pediatric patients with neurofibromatosis type 1-associated plexiform neurofibromas.
Ocugen (OCGN) shares were up more than 1% after saying it has completed dosing in the third cohort of its phase 1/2 clinical trial of OCU410ST, a modifier gene therapy candidate being developed for Stargardt disease.
Comments